Bentsur Ron

Avg. Two Year Performance

389% Avg. Purchase Return
121% Compound
48% Avg. Sale Return
22% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return19%34%79%213%389%
Purchase Success Rate5 of 114 of 116 of 114 of 115 of 11
Average Sale Return5%7%19%50%48%
Sale Success Rate9 of 2210 of 229 of 228 of 2210 of 22
Drugs » Drug Manufacturers - Major

Chief Executive Officer, Director:

Holdings: 777.21K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Executive Officer, Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chairman & CEO, Director, 10% Owner:

Holdings: 3.27M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CEO:

Holdings: 20.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 144.74K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--